presented by October Netherlands
lent to this project, means…
paid back in total
taxes not includedCreate your account
Warning Lending money to SMEs presents a risk of capital loss and requires your savings to be immobilised.
Information & Communication
Created in 24-03-2017, New Patientline B.V. is active in the Infotainment and IT services sector. The company, managed by Willem-Jan te Riele, has 11 employees and is based in Zaltbommel. The business was bought out of bankruptcy by the current shareholders who saw potential in the New Patientline business unit by renewing the value proposition.
Nowadays the company is active under the name brand name Sentean Hospitality Group and supplies their own software application (www.sentean.nl) and hardware for their hospitality proposition in healthcare & hospitality environment. The turnaround has been successful. Currently the company is profitable with good growth prospects.
Mr. Willem-Jan te Riele, managing director, has overall 22 years of professional experience in the infotainment & IT sector sector. Previously, he was managing director at VDA Group company for Benelux & DACH. company.
The company’s main activity is:
– the supply of Infotainment Solutions and IT Services for hospitality management in healthcare institutions
The company works with The company works with 50 large hospitals, hotels and Care properties in The Netherlands and is the market leader in the Cure sector
Elbuco B. V. wants to sell his stake in New Patientline B. V. , valuation based on standard of the market. Mr. Willem-Jan te Riele and Jan Catsburg via a dedicated company wish to borrow 619,000 € over 48 months to finance the acquisition of the company. This project will be realised next month.
This project is a Flexible Bridge Loan, an amortizable loan with a standard commitment for the first 9 months and the possibility of early repayment at no cost for the remainder of the loan term, even in the event of refinancing by other financial institutions.
The amount offered on the platform is limited to 303310€, which is in line with the regulatory limits.